CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in DNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,037,575

-$939,856 QoQ

Shares Held

332,394

-7.2% QoQ

Ownership

0.509%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. DNA ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,037,575	332,394	-7.2%	Shares	Sole	2026-05-15
2025-12-31	$2,977,431	358,295	+4.3%	Shares	Sole	2026-02-13
2025-09-30	$5,009,075	343,558	+3.6%	Shares	Sole	2025-11-10
2025-06-30	$3,729,813	331,539	+42.2%	Shares	Sole	2025-08-12
2025-03-31	$1,328,955	233,150	-0.2%	Shares	Sole	2025-09-15
2024-12-31	$2,295,100	233,717	+8.0%	Shares	Sole	2025-02-06
2024-09-30	$1,763,211	216,345	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.